Propel Bio Management, LLC
Source: SEC Form 13F · as of Mar 2026Propel Bio Management, LLC holds 21 biotech & pharma companies tracked by BioSniper, totaling $62.8M in value as of Mar 2026 (SEC Form 13F).
Companies held
21
Total value held
$62.8M
BioSniper AIPage evidence connected
Prepared research question
What matters most for ABEONA THERAPEUTICS INC. (ABEO)—catalysts, financial risk and supporting evidence?
Run cited research
Traceable citations · Unknowns marked
| Company | Shares | Value |
|---|---|---|
| ABEOABEONA THERAPEUTICS INC. | 1,329,899 | $6.0M |
| MISTMilestone Pharmaceuticals Inc. | 4,118,321 | $5.1M |
| CLDXCelldex Therapeutics, Inc. | 131,364 | $4.1M |
| CMPSCOMPASS Pathways plc | 742,049 | $4.1M |
| VRDNViridian Therapeutics, Inc.\DE | 210,163 | $4.1M |
| IVAInventiva S.A. | 724,678 | $4.0M |
| SABSSAB BIOTHERAPEUTICS, INC. | 1,012,790 | $3.9M |
| FDMT4D Molecular Therapeutics, Inc. | 380,420 | $3.6M |
| OCULOCULAR THERAPEUTIX, INC | 382,375 | $3.2M |
| UPBUpstream Bio, Inc. | 341,779 | $3.1M |
| AQSTAquestive Therapeutics, Inc. | 710,988 | $3.0M |
| ZVRAZEVRA THERAPEUTICS, INC. | 282,418 | $2.6M |
| IMUXIMMUNIC, INC. | 2,344,779 | $2.6M |
| CHRSCoherus Oncology, Inc. | 1,420,550 | $2.4M |
| OVIDOvid Therapeutics Inc. | 921,457 | $2.0M |
| KLRSKalaris Therapeutics, Inc. | 295,771 | $1.7M |
| QUREuniQure N.V. | 104,772 | $1.7M |
| LONALeonaBio, Inc. | 149,279 | $1.5M |
| NUVBNuvation Bio Inc. | 329,296 | $1.4M |
| MAZEMaze Therapeutics, Inc. | 43,798 | $1.3M |
| ALDXAldeyra Therapeutics, Inc. | 730,606 | $1.2M |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.